Navigation Links
Cardinal Health Launches Pyxis(R) MedStation(R) 4000; Introduces Industry-First Service to Interpret Dispensing and Infusion Data
Date:12/8/2008

sed on data specific to an individual hospital, Cardinal Health medication management experts provide customized recommendations that can be used to help improve medication safety and clinical practice at the facility.

This first-of-its-kind service for hospitals lessens raw data review by hospital staff to allow more time for patient care and eliminates the need to outsource costly device data management to a third party. The new Performance Analytics Service also alerts health care providers to potential risks of drug diversion and identifies opportunities to improve inventory management efficiency.

"The Pyxis(R) MedStation(R) 4000 builds on our leadership in helping prevent medication errors that lead to patient harm and higher costs for hospitals," said David Schlotterbeck, vice chairman of Cardinal Health and CEO of its Clinical and Medical Products segment. "Our new Performance Analytics Service leverages decades of Cardinal Health's medication management expertise to provide hospitals with recommendations to improve their dispensing and infusion processes to ensure optimal patient safety."

Cardinal Health highlighted these and other key medication management solutions at the 43rd Mid-Year Clinical Meeting and Exhibition for the American Society of Health-System Pharmacists (ASHP), taking place December 7-11 in Orlando, Fla.

Other key offerings highlighted by Cardinal Health at the industry event include:

-- A new version of the Pyxis PARx(R) pharmacy auto-replenishment system, to help ensure the accuracy of medications picked in the pharmacy and delivered to the Pyxis(R) MedStation(R) 4000 system through automated scanning technology;

-- New STAT identification features and advanced reporting capabilities for the new version of the Pyxis(R) Connect physician order management system, to help pharmacists efficiently evaluate the safety and appropriateness
'/>"/>

SOURCE Cardinal Health, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cardinal Health Establishes $1 Million Grant Fund for Initiatives That Improve Quality, Safety of Patient Care
2. New York Strengthens Emergency Preparedness with Cardinal Health Ventilators
3. Campbell Alliance Adds Doug Linton, Former Cardinal Health Executive, to Executive Advisory Group
4. Cardinal Health, Prime Therapeutics Sign Primary Distribution Agreement
5. Cardinal Health Invites Health Care Providers to Apply for $1 Million in Grants to Fund Patient Safety Initiatives
6. Hearing Scheduled in the Delaware Court of Chancery for August 27, 2007 to Establish the Valid Approval and Consummation of the Merger Between PharmAthene, Inc. and Healthcare Acquisition Corp.
7. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
8. Healthcare Technologies Calls for a Shareholders Meeting to Approve the Nexgen Biofuels Transaction
9. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
10. Ohio Ranks Best in the Midwest for Venture Capital Investment in Health Care Bioscience Industry
11. Proceedings to Affirm Merger Between PharmAthene and Healthcare Acquisition Corp Initiated in Delaware Chancery Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... RIDGE, N.J. (PRWEB) December 17, 2014 ... (Euronext: IPN; ADR: IPSEY), today ... mg (referred to as Somatuline®) was approved by ... the treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) in ... locally advanced or metastatic disease to improve progression-free ...
(Date:12/17/2014)... (PRWEB) December 17, 2014 Xeno ... Excellence following its most recent COLA inspection. Xeno ... COLA, a national healthcare accreditation organization. Accreditation is ... of quality in day-to-day operations, demonstrate continued accuracy ... a rigorous on-site laboratory survey. , ...
(Date:12/17/2014)... , Dec. 16, 2014  Vermillion, Inc. (NASDAQ: ... gynecologic disease, today announced the next step in its ... bio-analytics solutions provider with the naming of current Chief ... Chief Executive Officer, while current Chairman of the Board ... serve as Chairman. These changes are effective January 1, ...
(Date:12/17/2014)... , Dec. 17, 2014 Tigercat ... Phase 2 study evaluating the investigational oral NK-1 ... patients with severe, chronic itch who are unresponsive ... care, including topical steroids and antihistamines. ... in Visual Analog Scale (VAS) itch score from ...
Breaking Biology Technology:Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 2Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 3Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 4Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 5Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 6Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 7Ipsen Announces the FDA Approval of Somatuline® Depot® (lanreotide) Injection for the Treatment of Gastroenteropancreatic Neuroendocrine Tumors 8Xeno Diagnostics Receives 3rd Award for Laboratory Excellence 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 2Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 3Velocity Pharmaceutical Development, LLC and Tigercat Pharma, Inc. Announce Phase 2 Results for VPD-737 in Patients With Chronic Pruritus 4
... decidedly hostile environment, the lowly tapeworm uses a chemical trick ... ,Capitalizing on that tapeworm chemistry, scientists at the University of ... the transit of drugs through the intestine, making them more ... only of more effective treatment, but also of lowering dosage ...
... Secure Solution For Mobile and Content Service Providers ... Network365 announced today a joint initiative to co-market ... additional revenue for mobile operators. The ADC/Network365 solution ... between operators, banks and service providers which then ...
... Copaescu, then a second-year MBA in the University of Wisconsin's ... Technology Business Plan Competition, she knew she wanted to enter. ... the money definitely got her attention. It was the sudden ... her deepest dreams. "Even as a child growing up in ...
Cached Biology Technology:Tapeworm's Chemical Trick Could Make Drugs More Effective 2ADC and Network365 Team to Offer New End-to-End Mobile Payment System 2Romanian Student Leverages Burrill Competition to Accomplish Her Dream 2Romanian Student Leverages Burrill Competition to Accomplish Her Dream 3
(Date:12/17/2014)... Dec. 16, 2014 Valencell, a leader in ... biometric technology to industry leaders such as Intel, Jabra, ... validated, biometric wearable products. These products will be showcased ... Las Vegas . "Our ... flexible and robust – with the clinical data to ...
(Date:12/17/2014)... -- Automation is fundamentally transforming the travel experience and ... borders. Over the past decade, ePassports, biometric readers, ... to self process through border control via eGates ... increasing number of airports, seaports, and land borders ... Maxine Most , Principal at Acuity Market ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... have developed a way to produce sharp fluid jets with ... living cell. The technique promises a way to deliver drugs ... be very valuable for research involving stem cells and other ... the APS journal Physical Review Letters . The ...
... - Greenhouse gas markets, where invisible gases are ... people. Farmers can make money on these markets, ... methane capture technologies in animal-based systems, no-till farming, ... extension educators, offset aggregators, and other stakeholders need ...
... release is available in German . , Spectroscopic ... can look inside materials. They exploit the interaction of light ... absorption spectroscopy, researchers from Helmholtz-Zentrum Berlin fr Materialien und Energie ... to solvent so-called electron transfer. They can even make ...
Cached Biology News:Greenhouse gas calculator connects farming practices with carbon credits 2Help from the dark side 2
Highly efficient electroporation solution suitable for transfection of plasmid DNA, oligonucleotides and siRNA. Compatible with all common electroporators....
Removes polysaccharide and phenolic inhibitors of PCR; yields DNA greater than 50 kb in length...
...
...
Biology Products: